These data suggest a possible role for eEF2K/eEF2 signalling in driving an aggressive leukemia model and demonstrate that targeting mTORC1-eEF2K signalling can inactivate eEF2 and potentially deregulate protein translation elongation. Here, EEF2K is linked to leukemia.